An allergic reaction is an exaggerated immune response to a normally harmless substance known as an allergen. When a sensitive individual encounters an allergen, the body produces immunoglobulin E (IgE) antibodies. These antibodies bind to mast cells and basophils, sensitizing them to future exposures. Upon re-exposure, the allergen cross-links with IgE, triggering degranulation and the massive release of inflammatory mediators, primarily histamine.
Pharmacological management aims to block these chemical mediators or prevent their release. Understanding this pathophysiology helps nurses anticipate why certain drugs work rapidly while others take days to show clinical effects.
Antihistamines competitively block histamine receptors, preventing histamine from binding and exerting its effects. They are divided into two main generations:
Corticosteroids are potent anti-inflammatory agents used when antihistamines fail to control moderate to severe allergic responses. They inhibit the enzyme phospholipase A2, halting the arachidonic acid cascade and suppressing both prostaglandin and leukotriene production.
Because they modify gene transcription and protein synthesis, corticosteroids have a delayed onset of action, typically hours to days. They are crucial in managing delayed hypersensitivity reactions, contact dermatitis, and severe asthma exacerbations. Long-term systemic use requires gradual tapering to allow the adrenal glands to resume natural hormone production.
Anaphylaxis is a life-threatening, systemic allergic reaction characterized by airway swelling, severe bronchospasm, and profound hypotension. Epinephrine is the absolute first-line drug of choice and must be administered immediately intramuscularly into the anterolateral thigh.
As a potent alpha and beta adrenergic agonist, epinephrine reverses life-threatening symptoms through distinct mechanisms:
For chronic allergy control, such as allergic rhinitis and asthma prophylaxis, practitioners use prophylactic medications. Mast cell stabilizers like cromolyn sodium prevent the release of inflammatory chemicals by stabilizing the cell membrane against antigen triggers. They have a very high safety profile but require multiple daily doses because their onset is slow.
Leukotriene receptor antagonists like montelukast block leukotrienes from binding to their target receptors in the respiratory tract, reducing mucus production, bronchoconstriction, and local swelling. These drugs are taken orally and serve as effective maintenance therapy rather than rescue medications.
Comprehensive nursing care involves continuous assessment before, during, and after allergy medication administration. Nurses must check for a history of drug hypersensitivities, review current medication profiles for potential central nervous system depressant interactions, and monitor vital signs closely.
When administering intravenous or intramuscular emergency drugs, nurses must monitor for injection site reactions, tachycardia, and hypertension. Patient teaching must accompany every drug distribution, ensuring the client understands correct device usage, timing, and warning signs of worsening allergic disease.
Medical therapy is most effective when combined with strict environmental avoidance of known allergens. Nurses educate patients on identifying triggers such as pollen, dust mites, pet dander, and specific foods.
For patients prescribed auto-injector devices like the EpiPen, teaching must include a hands-on demonstration using a trainer device. Clients must verify expiration dates regularly, protect the medication from extreme heat and light, and know when to seek emergency medical help immediately even after self-administering rescue treatment.